Innate/inflammatory bioregulation and clinical effectiveness of whole-body hyperthermia (balneotherapy) in elderly patients with osteoarthritis

References

• Glyn-Jones S, Palmer AJR, Agricola R, et al. Osteoarthritis. Lancet. 2015;386(9991):376–387.
   PubMed Web of Science ®Google Scholar
• Kapoor M. Pathogenesis of osteoarthritis. In: Kapoor M, Mahomed NN, editors. Osteoarthritis. Pathogenesis, diagnosis, available treatments, drug safety, regenerative and precision medicine. Switzerland: Springer; 2015. p. 1–28.
   Google Scholar
• Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone. 2016;85:81–90.
   PubMed Web of Science ®Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33–42.
   PubMed Web of Science ®Google Scholar
• Loeser RF, Goldring SR, Scanzello CR, et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64:1697–1707.
   PubMed Web of Science ®Google Scholar
• Sohn D, Sokolove J, Sharpe O, et al. Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via toll-like receptor 4. Arthritis Res Ther. 2012;14(1):R7.
   PubMed Web of Science ®Google Scholar
• Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage. 2013;21(1):16–21.
   Web of Science ®Google Scholar
• Galvez I, Torres-Piles S, Hinchado MD, et al. Immune-neuroendocrine dysregulation in patients with osteoarthritis: a revision and a pilot study. Endocr Metab Immune Disord Drug Targets. 2017;17(1):78–85.
   PubMed Web of Science ®Google Scholar
• Li Y, Luo W, Zhu S, et al. T cells in osteoarthritis: alterations and beyond. Front Immunol. 2017;8:356.
   PubMed Web of Science ®Google Scholar
• Perrucio AV, Chandran V. Safety profile of current oa therapies: evidence from clinical trials. In: Kapoor M, Mahomed NN, editors. Osteoarthritis. pathogenesis, diagnosis, available treatments, drug safety, regenerative and precision medicine. Switzerland: Springer; 2015. p. 211–235.
   Google Scholar
• Gomes C, Carretero MI, Pozo M, et al. Peloids and pelotherapy: historical evolution, classification and glossary. Appl Clay Sci. 2013;75–76:28–38.
   Web of Science ®Google Scholar
• Gálvez I, Torres-Piles S, Ortega-Rincón E. Balneotherapy, immune system, and stress response: a hormetic strategy? Int J Mol Sci. 2018;19(6): pii: E1687.
   PubMed Web of Science ®Google Scholar
• Odabasi E, Turan M, Erdem H, et al. Does mud pack treatment have any chemical effect? A randomized controlled clinical study. J Altern Complement Med. 2008;14(5):559–565.
   PubMed Web of Science ®Google Scholar
• Ortega E, Gálvez I, Hinchado MD, et al. Anti-inflammatory effect as a mechanism of effectiveness underlying the clinical benefits of pelotherapy in osteoarthritis patients: regulation of the altered inflammatory and stress feedback response. Int J Biometeorol. 2017;61(10):1777–1785.
   PubMed Web of Science ®Google Scholar
• Forestier R, Erol-Forestier FB, Francon A. Current role for spa therapy in rheumatology. Joint Bone Spine. 2017;84(1):9–13.
   PubMed Web of Science ®Google Scholar
• Harzy T, Ghani N, Akasbi N, et al. Short- and long-term therapeutic effects of thermal mineral waters in knee osteoarthritis: a systematic review of randomized controlled trials. Clin Rheumatol. 2009;28(5):501–507.
   PubMed Web of Science ®Google Scholar
• Fioravanti A, Iacoponi F, Bellisai B, et al. Short- and long-term effects of spa therapy in knee osteoarthritis. Am J Phys Med Rehabil. 2010;89(2):125–132.
   PubMed Web of Science ®Google Scholar
• McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363–388.
   PubMed Web of Science ®Google Scholar
• Espejo-Antúnez L, Caro-Puértolas B, Ibáñez-Burgos B, et al. Effects of mud therapy on perceived pain and quality of life related to health in patients with knee osteoarthritis. Reumatol Clin. 2013;9(3):156–160.
   PubMedGoogle Scholar
• Fioravanti A, Bacaro G, Giannitti C, et al. One-year follow-up of mud-bath therapy in patients with bilateral knee osteoarthritis: a randomized, single-blind controlled trial. Int J Biometeorol. 2015;59(9):1333–1343.
   PubMed Web of Science ®Google Scholar
• Ciani O, Pascarelli NA, Giannitti C, et al. Mud-bath therapy in addition to usual care in bilateral knee osteoarthritis: an economic evaluation alongside a randomized controlled trial. Arthritis Care Res. 2017;69(7):966–972.
   Web of Science ®Google Scholar
• Gutenbrunner C, Bender T, Cantista P, et al. A proposal for a worldwide definition of health resort medicine, balneology, medical hydrology and climatology. Int J Biometeorol. 2010;54(5):495–507.
   PubMed Web of Science ®Google Scholar
• Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039–1049.
   PubMed Web of Science ®Google Scholar
• Carretero MI, Pozo M, Martín-Rubí JA, et al. Mobility of elements in interaction between artificial sweat and peloids used in Spanish spas. Appl Clay Sci. 2010;48(3):506–515.
   Web of Science ®Google Scholar
• Pozo M, Carretero MI, Maraver F, et al. Composition and physico-chemical properties of peloids used in Spanish spas: a comparative study. Appl Clay Sci. 2013;83–84:270–279.
   Web of Science ®Google Scholar
• Scott J, Huskisson EC. Graphic representation of pain. Pain. 1976;2(2):175–184.
   PubMed Web of Science ®Google Scholar
• Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–1840.
   PubMed Web of Science ®Google Scholar
• The EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
   PubMed Web of Science ®Google Scholar
• Evcik D, Kavuncu V, Yeter A, et al. The efficacy of balneotherapy and mud-pack therapy in patients with knee osteoarthritis. Joint Bone Spine. 2007;74(1):60–65.
   PubMed Web of Science ®Google Scholar
• Fioravanti A, Cantarini L, Guidelli GM, et al. Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? Rheumatol Int. 2011;31(1):1–8.
   PubMed Web of Science ®Google Scholar
• Pascarelli NA, Cheleschi S, Bacaro G, et al. Effect of mud-bath therapy on serum biomarkers in patients with knee osteoarthritis: results from a randomized controlled trial. Isr Med Assoc J. 2016;18(3–4):232–237.
   PubMed Web of Science ®Google Scholar
• Fioravanti A, Giannitti C, Cheleschi S, et al. Circulating levels of adiponectin, resistin, and visfatin after mud-bath therapy in patients with bilateral knee osteoarthritis. Int J Biometeorol. 2015;59(11):1691–1700.
   PubMed Web of Science ®Google Scholar
• Giannitti C, De Palma A, Pascarelli NA, et al. Can balneotherapy modify microRNA expression levels in osteoarthritis? A comparative study in patients with knee osteoarthritis. Int J Biometeorol. 2017;61(12):2153–2158.
   PubMed Web of Science ®Google Scholar
• Kapetanakis S, Drygiannakis I, Kazakos K, et al. Serum TGF-beta2 and TGF-beta3 are increased and positively correlated to pain, functionality, and radiographic staging in osteoarthritis. Orthopedics. 2010;33(8).
   Google Scholar
• Ortega E, Bote ME, Giraldo E, et al. Aquatic exercise improves the monocyte pro- and anti-inflammatory cytokine production balance in fibromyalgia patients. Scand J Med Sci Sports. 2012;22(1):104–112.
   PubMed Web of Science ®Google Scholar
• Cunha FQ, Lorenzetti BB, Poole S, et al. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol. 1991;104(3):765–767.
   PubMed Web of Science ®Google Scholar
• Sutton S, Clutterbuck A, Harris P, et al. The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis. Vet J. 2009;179(1):10–24.
   PubMed Web of Science ®Google Scholar
• Konya C, Goronzy JJ, Weyand CM. Treating autoimmune disease by targeting CD8+ T suppressor cells. Expert Opin Biol Ther. 2009;9(8):951–965.
   PubMed Web of Science ®Google Scholar
• Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8(7):523–532.
   PubMed Web of Science ®Google Scholar
• Vuddamalay Y, van Meerwijk JPM. CD28− and CD28lowCD8+ regulatory t cells: of mice and men. Front Immunol. 2017;8:31.
   PubMedGoogle Scholar
• Davila E, Kang YM, Park YW, et al. Cell-based immunotherapy with suppressor CD8+ T cells in rheumatoid arthritis. J Immunol. 2005;174(11):7292–7301.
   PubMed Web of Science ®Google Scholar
• Li S, Wan J, Anderson W, et al. Downregulation of IL-10 secretion by Treg cells in osteoarthritis is associated with a reduction in Tim-3 expression. Biomed Pharmacother. 2016;79:159–165.
   PubMed Web of Science ®Google Scholar
• Guo SY, Ding YJ, Li L, et al. Correlation of CD4+ CD25+ Foxp3+ Treg with the recovery of joint function after total knee replacement in rats with osteoarthritis. Genet Mol Res. 2015;14(3):7290–7296.
   PubMed Web of Science ®Google Scholar
• Xia J, Ni Z, Wang J, et al. Overexpression of Lymphocyte Activation gene-3 inhibits regulatory T cell responses in osteoarthritis. DNA Cell Biol. 2017;36(10):862–869.
   PubMed Web of Science ®Google Scholar
• Gol-Ara M, Jadidi-Niaragh F, Sadria R, et al. The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis. Arthritis. 2012;2012:805875.
   PubMedGoogle Scholar
• De la Fuente M, Cruces J, Hernandez O, et al. Strategies to improve the functions and redox state of the immune system in aged subjects. Curr Pharm Des. 2011;17(36):3966–3993.
   PubMed Web of Science ®Google Scholar
• Forner MA, Barriga C, Rodriguez AB, et al. A study of the role of corticosterone as a mediator in exercise-induced stimulation of murine macrophage phagocytosis. J Physiol. 1995;488(Pt 3):789–794.
   PubMed Web of Science ®Google Scholar
• Ortega E. Neuroendocrine mediators in the modulation of phagocytosis by exercise: physiological implications. Exerc Immunol Rev. 2003;9:70–93.
   PubMed Web of Science ®Google Scholar
• Ortega E. The “bioregulatory effect of exercise” on the innate/inflammatory responses. J Physiol Biochem. 2016;72:361–369.
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Chrousos GP. Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab. 1999;10(9):359–368.
   PubMed Web of Science ®Google Scholar